Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Transcripts
    • AGM Invitations
    • IPOs
  • inderesTV
  • Forum
  • Discovery
  • About Us
    • Our Coverage
    • Team
Regulatory press release

AddLife donates medical devices to Ukraine

AddLife
Read the release

AddLife has today donated medical devices for critical care to Ukraine at an approximated amount of SEK 7 million. The donation has been made in coordination with the Ukraine embassy in Stockholm and Ukraine Ministry of Foreign Affairs to meet specified needs from their health department.

The products are currently being transported to the border between Poland and Ukraine. The initiative is a collaboration between the group companies Mediplast (Sweden) and Healthcare 21 (UK & Ireland) with support from Biomedica Medizinprodukte's (Austria) local office in Poland.

We want to recognize the strong engagement and extra work by our employees for making this initiative happen.

Stockholm 4 March 2022
AddLife AB (publ)

For further information, please contact:
Kristina Willgård, VD, AddLife AB, +46 (0)705 10 12 23

AddLife is an independent European player in Life Science that offers high-quality products, services and consulting to both the private and public sectors. AddLife has about 2,200 employees in around 80 operating subsidiaries, which operate under their own brands. The Group has annual sales of approximately SEK 8 billion. AddLife is listed on the NASDAQ Stockholm stock exchange.

This information was issued for publication on 4 March 2022 at 12:00 CET.

[image]

Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.